MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited Total Liabilities 2011-2026 | VNRX
Annual Total Liabilities VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.5 M | 36.7 M | 21.4 M | 9.77 M | - | 7.09 M | 5.35 M | 4.67 M | 3.56 M | 1.67 M | 3.06 M | 1.39 M | 1.38 M | 130 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 36.7 M | 130 K | 10.1 M |
Quarterly Total Liabilities VolitionRx Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42.4 M | 41.8 M | 37.5 M | 35.5 M | 35.3 M | 36 M | 36.1 M | 36.7 M | 20.9 M | 22.4 M | 21 M | 21.4 M | 20.5 M | 20.3 M | 20.9 M | 9.77 M | 8.82 M | 8.61 M | 9.35 M | 9.86 M | 9.86 M | 9.86 M | 9.86 M | 7.09 M | 7.09 M | 7.09 M | 7.09 M | 5.35 M | 5.35 M | 5.35 M | 5.35 M | 4.67 M | 4.67 M | 4.67 M | 4.67 M | 3.56 M | 3.56 M | 3.56 M | 3.56 M | 1.67 M | 1.67 M | 1.67 M | 1.67 M | 3.06 M | 3.06 M | 3.06 M | 3.06 M | 1.39 M | 1.39 M | 1.39 M | 1.39 M | 1.38 M | 1.38 M | 1.38 M | 1.38 M | 1.16 M | 1.16 M | 1.16 M | 1.16 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 42.4 M | 1.16 M | 10.9 M |
Total Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
14.4 M | $ 24.58 | 1.91 % | $ 99.4 M |  Israel |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.12 | -0.88 % | $ 1.42 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 28.4 | -1.41 % | $ 306 M |  China |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
87.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Celcuity
CELC
|
130 M | $ 106.01 | 0.82 % | $ 4.18 B | USA |
 |
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
21.6 M | - | - | $ 562 M |  Britain |
 |
Check-Cap Ltd.
CHEK
|
1.83 M | - | - | $ 9.42 M | Israel |
 |
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
DarioHealth Corp.
DRIO
|
7.26 M | $ 11.26 | - | $ 319 M | Israel |
 |
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
9.31 M | - | - | $ 79.8 M | USA |
 |
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | USA |
 |
Fulgent Genetics
FLGT
|
90.8 M | $ 23.02 | 0.04 % | $ 696 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.37 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | China |
 |
Quest Diagnostics Incorporated
DGX
|
7.16 B | $ 209.34 | 0.95 % | $ 23.2 B | USA |
 |
Castle Biosciences
CSTL
|
75.4 M | $ 30.02 | 3.73 % | $ 834 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
205 M | $ 19.18 | 2.08 % | $ 1.03 B | USA |
 |
Danaher Corporation
DHR
|
31.8 B | $ 209.79 | -0.58 % | $ 153 B | USA |
 |
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | USA |
 |
DexCom
DXCM
|
3.59 B | $ 72.99 | -0.38 % | $ 28.5 B | USA |
 |
Interpace Biosciences
IDXG
|
17 M | $ 1.74 | -5.95 % | $ 7.63 M | USA |
 |
Exact Sciences Corporation
EXAS
|
3.46 B | $ 103.46 | 0.07 % | $ 19.5 B | USA |
 |
Guardant Health
GH
|
2.11 B | $ 96.45 | 2.15 % | $ 12.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.11 B | - | - | $ 10.6 B |  Niderland |
 |
Laboratory Corporation of America Holdings
LH
|
9.76 B | $ 287.1 | 0.62 % | $ 24.1 B | USA |
 |
Charles River Laboratories International
CRL
|
3.92 B | $ 166.77 | 1.98 % | $ 8.27 B | USA |
 |
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
7.35 B | $ 104.81 | 0.14 % | $ 8.65 B |  Irlanda |
 |
ENDRA Life Sciences
NDRA
|
1.89 M | $ 3.77 | 0.53 % | $ 2.02 M | USA |
 |
IDEXX Laboratories
IDXX
|
1.75 B | $ 648.66 | 4.1 % | $ 52.2 B | USA |
 |
Illumina
ILMN
|
2.7 B | $ 123.46 | 2.42 % | $ 19.6 B | USA |
 |
IQVIA Holdings
IQV
|
23.3 B | $ 164.94 | 1.75 % | $ 28.4 B | USA |
 |
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | Israel |
 |
Koninklijke Philips N.V.
PHG
|
16.9 B | $ 31.48 | 0.82 % | $ 20 B | Niderland |
 |
Mettler-Toledo International
MTD
|
3.74 B | $ 1 382.99 | -0.81 % | $ 28.5 B |  Schweiz |
|
Biodesix
BDSX
|
76.4 M | $ 13.28 | 3.99 % | $ 1.72 B | USA |
 |
Quidel Corporation
QDEL
|
538 M | $ 22.06 | 4.11 % | $ 929 M | USA |
 |
Natera
NTRA
|
689 M | $ 209.72 | 0.18 % | $ 20.6 B | USA |
 |
Lantheus Holdings
LNTH
|
892 M | $ 73.43 | 0.01 % | $ 5.08 B | USA |
 |
Biomerica
BMRA
|
1.84 M | $ 2.11 | 0.49 % | $ 4.85 M | USA |
 |
Bioventus
BVS
|
590 M | $ 8.71 | 0.58 % | $ 546 M | USA |
 |
Medpace Holdings
MEDP
|
1.52 B | $ 442.92 | -0.46 % | $ 12.8 B | USA |